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Abstract
Hypertension is caused by the interaction of environmental and genetic factors. The condition which is very common, with
about 18% of the adult Hong Kong Chinese population and over 50% of older individuals affected, is responsible for
considerable morbidity and mortality. To identify genes influencing hypertension and blood pressure, we conducted a
combined linkage and association study using over 500,000 single nucleotide polymorphisms (SNPs) genotyped in 328
individuals comprising 111 hypertensive probands and their siblings. Using a family-based association test, we found an
association with SNPs on chromosome 5q31.1 (rs6596140; P,9610
28) for hypertension. One candidate gene, PDC, was
replicated, with rs3817586 on 1q31.1 attaining P=2.5610
24 and 2.9610
25 in the within-family tests for DBP and MAP,
respectively. We also identified regions of significant linkage for systolic and diastolic blood pressure on chromosomes 2q22
and 5p13, respectively. Further family-based association analysis of the linkage peak on chromosome 5 yielded a significant
association (rs1605685, P,7610
25) for DBP. This is the first combined linkage and association study of hypertension and its
related quantitative traits with Chinese ancestry. The associations reported here account for the action of common variants
whereas the discovery of linkage regions may point to novel targets for rare variant screening.
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Introduction
Hypertension, which affects nearly 27% of the population
worldwide [1], is a major cause of cardiovascular morbidity and
mortality [2]. The condition is highly heritable and polygenic, caused
by the combination of small changes in the expression of many genes,
and interaction of these genes with multiple environmental factors
[3]. The identification of allelic variation affecting blood pressure in
the general population would advance our understanding of blood
pressure regulation and may contribute to the development of
approaches for prevention and treatment of hypertension in the
future.
The high heritability (30–60%) of blood pressure has prompted
extensive efforts to dissect its genetic basis [4]. In the 90 s and the
early part of the present decade, genome-wide linkage analysis had
been one of the main strategies for identifying hypertension
susceptibility genes. It involves the genotyping of hundreds or
thousands of markers in families with one or more hypertensives.
Using this method, linkage studies have found significant or
suggestive loci influencing blood pressure as a quantitative trait
or hypertension as a qualitative trait [5,6,7,8,9]. These results
indicate that no single genomic region has a uniformly large effect
on predisposition to hypertension. Over 100 hypertension-related
quantitative trail loci (QTLs) have been demonstrated across the
genome; however, the indicated linkage peaks have been too
broad and unstable, likely due to insufficient sample size and the
highly polygenic nature of the condition, and as a result there have
been few replications between populations [10].
Genome-wide association studies (GWAS), using hundreds of
thousands of single nucleotide polymorphism (SNP) markers, are
the current method of choice for dissecting the genetic basis
of complex disease and can provide a potentially more powerful
method of identifying the causal variants that underlie suscepti-
bility to common disease, including hypertension, as compared
to linkage analysis. From 2007 to 2009, there have been several
large-scale GWAS of hypertension. One of them [11] was carried
out by the Wellcome Trust Case Control Consortium (WTCCC)
and no significant variants were yielded in the initial and re-
plication stage of data analysis. A meta-analysis reported the
combined findings of two consortia: the Cohorts for Heart and
Aging Research in Genome Epidemiology (CHARGE) Consor-
tium and the Global BPgen Consortium, with very large study
samples of European ancestry [12,13]. Four loci for systolic blood
pressure (SBP), six for diastolic blood pressure (DBP) and one for
hypertension attained genome-wide significance. Studies from
the Global BPgen consortium, followed up by direct genotyping
and in silico comparison (CHARGE consortium), identified
association with SBP or DBP in eight regions. GWAS on young-
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population of Taiwan and located 4 SNPs with strong association
signals. Another GWAS [15] was conducted in the Old Order
Amish (a closed founder population of European origin) and
identified a novel susceptibility gene, STK39.
The present study used sibships recruited in Hong Kong, where
one member of the sibship is hypertensive and at least one
additional member is normotensive, with as many members of the
sibship included in the study as available. We employed the
Illumina HumanHap610-Quad Array for genotyping all pheno-
typed sibship members. This unique use of a family-based design
allows testing for both linkage and association for loci influencing
hypertension and its related quantitative traits. Here, we present
the extensive analyses performed using this high-density SNP data
and identify independent and novel genome-wide significant
results by both linkage and association analyses.
Methods
Ethics Statement
Thisstudy was approved by the Institutional Review Board of the
University of Hong Kong/Hospital Authority Hong Kong West
Cluster, reference UW06-177 T/1202. Consent was obtained from
all participants involved in this study with a Participant Information
Statement and Consent Form, which was approved by the ethics
committee.
Study samples
The hypertensive subjects were identified in the hypertension
and general outpatient clinics of the Prince of Wales Hospital in
Hong Kong and referred to the Clinical Pharmacology Studies
Unit (CPSU). Hypertensive probands were ascertained, along with
as many of their siblings who agreed to participate. Treatment for
hypertension was withdrawn to enable the determination of off-
treatment blood pressure (BP). Following withdrawal of antihy-
pertensive medication, subjects were monitored weekly to check if
their BP did not exceed the upper exclusion limit and to confirm
that they were not at risk from severe hypertension. After the four
to eight week washout period [16], the sitting SBP and DBP were
measured in triplicate after a 10 to 15 minute resting period. Mean
arterial pressure (MAP) was calculated from those measures
(MAP=[(26 DBP)+SBP]/3). Siblings with SBP .140 mm Hg
and/or DBP .90 mmHg were considered hypertensive, with
those remaining classified as normotensive. The sample included
328 individuals (143 males, 185 females) comprising 111 sibships
ranging in size from 2–8 sibs. The clinical characteristics of study
samples are shown in Table 1. The study was approved by the
Joint Chinese University of Hong Kong and New Territories East
Cluster Clinical Research Ethics Committee, Hong Kong. Signed
informed consent was obtained from the subjects.
Genotyping
Genotyping was performed by deCODE Genetics, Inc, using
the Illumina HumanHap 610-Quad BeadChip technology, which
enables whole-genome genotyping of 620,901 single nucleotide
polymorphisms (SNPs). Image intensities were extracted using
Illumina’s BeadScan software. Data for the BeadChip were self-
normalised using information contained within the array. Allele
calling was carried out using Illumina’s Genotyping Module
version 3.3.7 in BeadStudio version 3.1.3.0.
Data cleaning
Criteria for exclusion of individuals. The first stage of
data-cleaning examined the genetic relationships by checking the
genome-wide identity by descent (IBD) sharing for all pairs of
individuals in the sample after pruning markers in LD (r2.0.25).
Based on the pair-wise IBD estimation, 4 individuals distributed
in 4 families were recognized to be half-siblings to the probands
and recoded as such, and 6 individuals were excluded because
of sample contamination or unknown familial relationships.
Then, inbreeding coefficients were calculated, which found five
individuals with either strong positive or negative inbreeding
coefficient estimates, indicating that these individuals have more or
fewer homozygous genotypes than one would expect by chance,
reflecting potential sample contamination. Gender status was
also checked using the X chromosome data, which detected 10
problematic samples for whom the reported sex did not match the
estimated sex and were removed since these discrepancies could
not be reconciled with our records. After cleaning, 315 individuals
within 111 families remained.
Criteria for exclusion of SNPs. SNP genotyping quality
was evaluated by examining the genotyping call rate (GCR), the
minor allele frequency (MAF), and testing for Hardy-Weinberg
Equilibrium (HWE). 8400 SNPs with missing rate .5%, 92169
SNPs with MAF,0.01, and 1686 markers which violated HWE
(p,0.0001) were excluded from analysis. 503,984 SNPs passed
quality control (QC) and were used for analysis. The total GCR in
remaining individuals was 99.94%, with all chips having a call rate
.98%.
Statistical Analysis
In all linkage and association analyses, age, sex, and BMI
were used as covariates for DBP, SBP and MAP values. The
standardized values of the residuals obtained were all approxi-
mately normally distributed.
Family-based association analysis. Univariate family-
based association tests were conducted for quantitative traits of
DBP, SBP and MAP, and the disease trait of hypertension.
Quantitative trait association was performed using the QFAM
procedure in PLINK [17], which provides both a total test of
association and a within-family test, which is free from bias due
to population stratification. The tests employ a simple linear
regression of phenotype on genotype and use a permutation
procedure to correct for family structure.
For within-family tests, measures of three quantitative traits
were each adjusted for age, sex, and BMI. For the total association
test, in addition to the above three covariates, in an attempt to
correct for population stratification, the first principal component
extracted from an EIGENSTRAT [18] analysis was used as an
additional covariate. For analysis of the hypertension binary
disease trait, the DFAM procedure using the Cochran-Mantel-
Haenszel test was employed, which implements a within-family
test.
Linkage analysis. Linkage was evaluated using MERLIN-
REGRESS (version 1.1.2), a regression-based method suitable
for selected samples [19]. The method requires specification of
population estimates of the trait means and variances. We obtained
such estimates from a population-based cohort of Chinese subjects,
participating in the Hong Kong Cardiovascular Risk Factor Study
[20], shown in Table 1. The linkage analysis also requires speci-
fication of trait heritability, and 0.6 was used for all blood pressure
traits, as suggested by previous studies [21,22,23].
The presence of linkage disequilibrium (LD) among markers
violates an underlying assumption of linkage in multipoint linkage
approaches. Appropriate handling of marker LD can avoid such
false positive evidence [24]. MERLIN has a built-in option of
modeling LD (-rsq) by organizing markers into clusters using pre-
specified r
2 equal to 0.25 [25].
A Linkage and Association Study for Hypertension
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31489We also employed QTDT [26] to conduct a combined test of
linkage and association, which can help determine whether a
putative QTL locus detected via association is the actual disease-
causing locus or whether it is merely in disequilibrium with the
trait locus [27,28].
Results
Association analysis
The whole-genome association scan for hypertension (disease
status)andcorrespondingquantile-quantile (QQ)plot ofobservedp-
values against those expected under the null hypothesis are
presented in Figure S1. For the dichotomous variable of hyper-
tension, four independent signals were found with P#10
25, with
one SNP (rs6596140) attaining P,10
27 (Table S1). The location of
this SNP (5q31.1), marked by a strong recombination hotspot, is far
away from any annotated genes, and the nearest gene is follistatin-
like 4 (FSTL4) (.70 kb away) (Figure 1). FSTL4, a member of the
follistatin gene family of TGF-beta superfamily inhibitors, is widely
expressed in neurons, cardiac muscle cells, smooth muscle cells and
intestinalepithelium[29].Iftheassociated SNP istruly associated,it
may play a role in regulating this gene, or tagging another SNP
having such a role. Associations with SNPs outside of genes is a
common phenomenon in genome-wide association studies [30].
Results of the association analysis for the quantitative traits are
summarized in Figure S2 and Figure S3. For the within-family test
analysis, we observed 10 independent signals with P#10
25 for
DBP, 1 for SBP and 9 for MAP. For the total association test, we
observed 6 independent signals with P#10
25 for DBP, 1 for SBP
and 3 for MAP. Results of the most significant SNPs are presented
for the three quantitative traits in Table S2. The QQ plots of
observed p-values against those expected under the null hypothesis
suggest an excess of associations with DBP and MAP in within-
family tests, as compared to a null distribution of no associations,
but no distinct deviations for other tests (Figure S4). Population
stratification was not a problem in our data, as indicated by a
genomic inflation factor l=1, based on the median chi-square, for
all sets of tests, as expected with use of within-family tests of
association or when correcting for stratification as done for the
total test of association.
Nine of the SNPs listed in Table S3 are found using all three
continuous traits. Because the three traits are correlated (r,0.85–
0.90), this is not too surprising. The observation that each SNP
shows stronger association with one trait or another could reflect
sampling variation or true differences in the underlying biological
basis of the blood pressure traits.
For the nine SNPs that were significant in continuous trait analysis,
two markers (rs6596140 and rs6596142, r
2=0.84) were associated
with hypertension status, with P,9610
28 and ,6610
26,r e s p e c -
tively. Five other markers (rs4463623, rs4434808, rs1387343,
rs12930697, rs1550823) had moderate P values around .002 to
.0004. The other two markers (rs9325113, rs2075514) showed no
association.
We also looked for association signals at a subset of our SNPs
where there was previous evidence of involvement in hypertension,
from both genome-wide association studies [11,12,13,14,15,31,
32,33] and candidate gene studies [34,35,36], allowing for a much
less stringent multiple testing correction. For SNPs which were not
assayed by the Illumina 610-Quad, tag SNPs (r
2.0.8) were
selected instead. In total, this involved examining 101 SNPs. One
SNP in PDC on 1q31.1 was significantly associated after
Bonferroni correction for multiple testing of 101 SNPs, with
rs3817586 (tagging rs11812050, r
2=0.95) attaining P=2.5610
24
and 2.9610
25 in the within-family tests for DBP and MAP,
respectively. Nonetheless, when examining the QQ plot of these
tests (Figure S5), there were only small deviations from what is
expected under the null hypothesis, suggesting a lack of power.
Phosducin (Pdc), which was identified in retina and brain as a 33-
kDa protein and binds to the bc subunits of heterotrimeric GTP-
binding proteins [37,38], is a potential candidate gene for retinitis
pigmentosa [39]. Beetz et al. [35] investigated the role of the G
protein regulator Pdc in hypertension and found that Pdc was
significantly associated with both wake and stress-response blood
pressure phenotypes. It is demonstrated that PDC is an important
modulator of sympathetic activity and blood pressure and may
thus represent a promising target for treatment of stress-dependent
hypertension. The family-based association results of all three
quantitative traits (DBP, SBP and MAP) for the replicated 101
SNPs from previous studies are presented in Table S4.
Linkage analysis
Linkage plots from the multipoint analyses using MERLIN-
REGRESS are shown in Figure S6 for DBP, SBP and MAP.
Linkage analysis using DBP located the highest LOD score on
chromosome 5 (LOD=4.02, p,10
25) around 38 cM (1-LOD
support interval 34 to 39 cM). The nearest gene is GDNF,, glial cell
derived neurotrophic factor isoform, which encodes a highly
conserved neurotrophic factor and has been found to be associated
Table 1. Characteristics of the study and population samples.
Study samples Population samples
No. of subjects 315 2895
No. of families 111 -
Mean age (years) 6 standard deviation 40.367.9 45.8612.9
Sex (proportion male) 0.439 0.488
patients healthy siblings
Hypertension (dichotomous trait) 134 181 -
Mean body mass index(BMI), kg/m
2 26.963.8 24.063.4 28.463.5
Mean systolic blood pressure (SBP), mm Hg 151.2613.2 117.6611.2 119.3619.8
Mean diastolic blood pressure (DBP), mm Hg 93.869.4 70.0610.5 74.7610.8
Mean mean arterial pressure (MAP), mm Hg 113.4611.3 88.9611.0 89.6613.0
doi:10.1371/journal.pone.0031489.t001
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seen on chromosome 5 (LOD=3.85, p,10-5) at around 35 cM,
near AGXT2 which encodes the mitochondrial alanine-glyoxylate
aminotransferase. Baker et al. [42] cloned human AGXT2 and
their findings suggest that human hepatocyte mitochondria possess
AGXT2 activity. For the SBP phenotype, the highest peak was
found on chromosome 2 (LOD=3.01, p,10-4) at around 144 cM
(130–145 cM), encompassing ARHGAP15, or RHO GTPase-
activating protein 15. RHO GTPases regulate diverse biologic
processes, and their activity is regulated by RHO GTPase-
activating proteins (GAPs), such as ARHGAP15 [43]. Seoh et al.
[43] found that the GAP domain of ARHGAP15 showed specificity
toward RAC1 in vitro, suggesting that ARHGAP15 is a regulator
of RAC1. Suggestive linkage was found for MAP on chromosome
2 (LOD=2.34, P,.0005) at around 157 cM and chromosome
5 (LOD=2.31, P,.0006) at around 146 cM. The peak on
chromosome 2 encompasses one interesting gene, GPD2, which
encodes protein to localize to the inner mitochondrial membrane,
and also contributes to the genetic liability of type 2 diabetes
[44]. An interesting gene within the peak on chromosome 5 is
PPP2R2B, which encodes a brain-specific regulatory subunit B of
protein phosphatase 2. Although the precise role of the subunit
encoded by PPP2R2B remains to be determined, protein
phosphatase 2A (PP2A) has been implicated in a number of
cellular functions [45], including cell growth and division, muscle
contraction, and gene transcription.
In comparison of the linkage results with other studies in Chinese
populations, we found three regions with previous evidence of
linkage for hypertension (Figure S7). A linkage peak on chromosome
2q14-q23 for essential hypertension was previously detected in Han
Chinese, with a suggestive LOD of 2.24 at 160.52 cM [46]. Fang et
al. [47,48] found linkage to two genes, dopamine D2 receptor
(DRD2) and Angiotensinogen (AGT), with variants contributing an
increased risk of hypertension in Chinese subjects. Howerer, none of
these regions show strong linkage results in our study.
We also performed the simultaneous analysis of both linkage
and association for the three quantitative traits. In effect, this
allows partialing out the effects of association from the test of
linkage. Combined plots for the two chromosomes with strongest
linkage peaks (chromosomes 2 and 5) of the tests of within-family
association, tests of linkage (when not modeling association), and
the combined tests of linkage and association, are presented in
Figure 2. When linkage was tested without simultaneous modeling
of association, one significant LOD score of 4 for DBP on chro-
mosome 5 was found, along with a suggestive LOD score of 3 for
SBP on chromosome 2. By the inclusion of association, the extent
of linkage evidence was diminished substantially, with the linkage
peaks declining by over 1 LOD score. Nonetheless, since these
LOD scores did not decline to zero, it is doubtful that the
associated SNPs under these peaks were themselves causal and
instead they were likely tagging a causal variant. The strongest
peak containing the significant LOD=4 for DBP on chromosome
5 covered a range of 4 Mb with 808 markers, as defined by the
1=LOD support interval. Examination of the QQ plots for the
808 SNPs in this region, for both the within- and total-association
tests, suggests a clear deviation from that expected under the null
hypothesis (Figure S8). The most significant P value under the
linkage peak was for rs1605685 (p,7610
25) for DBP, which was
significant after Bonferroni correction for the 808 SNPs under the
peak, but no gene has been characterized around this SNP in the
literature.
Discussion
We tested 503,984 SNPs for association with hypertension status
and BP traits. Our study is the first report of a combined genome-
wide linkage and association scan for these traits in families with
Chinese ancestry. The two traits are correlated and heritable, and
SBP shows stronger increases with age, with DBP starting to
plateau and in some individuals fall at ages above 60–65 years
[49]. Some [50] have suggested the study of mean arterial
pressure, which increases with advancing age and is highly
correlated with SBP and DBP, also showed evidence of heri-
tability. In our GWAS, we chose to examine SBP, DBP and MAP
Figure 1. Regional plot of the strongest association for dichotomous hypertension. The plot highlights the statistical strength of the
strongest association (rs6596140, P,9610
28, blue diamond) and surrounding markers, along with the pair-wise correlations between the
surrounding markers and the putative associated variant, indicated by color. All SNPs in the region are plotted with their p-values (as –log10 values) as
a function of genomic position (using NCBI Build 36). Estimated recombination rates (taken from HapMap) are plotted to reflect the local LD structure
around the associated SNP and their correlated proxies (bright red indicating highly correlated, faint red indicating weakly correlated). The annotated
gene FSTL4 (taken from UCSC table browser) is more than 70 kb away from the associated SNP.
doi:10.1371/journal.pone.0031489.g001
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hypertension disease status.
We report significant genome-wide linkage as well as an
association of common genetic variants with hypertension. Our
linkage analysis revealed two novel regions of linkage for DBP,
5p13.1 and 5p13.2, formally achieving genome-wide significance,
and also one novel region for SBP, 2q22.3 (LOD=3.01). Our
association analysis has identified a significant variant (rs6596140)
for hypertension and also detected effects of relatively common
alleles with modest P values for quantitative traits. The region of
association (Figure 1) is limited to a 3-kb region flanked by strong
recombination hotspots, which are surrounded by multiple non-
coding sequences but no known genes. FSTL4, which is a key
modulator in muscle development, was specified as nominally
associated with increased risk of stroke in a cardiovascular health
study [51]. It is possible that the nearby associated SNP we
detected plays a regulatory role for FSTL4.
There is limited overlap between the regions of strongest linkage
and association. However, further assessment of SNP association
under the linkage peak on chromosome 5 did yield a significant
variant, rs1605685, after correcting for multiple testing of the 808
SNPs under the peak.
Figure 2. Combined plots for the tests of within-family association and tests of linkage, both in the presence and absence of
association. The genome-wide linkage results are shown, with the red lines indicating linkage tests (LOD) in the absence of association, and the
blue lines indicating linkage tests (LOD) in the presence of association. The grey dots indicate the within-family association results (-logP) in the
absence of linkage. All results are shown for DBP, SBP and MAP on chromosomes 2 and 5.
doi:10.1371/journal.pone.0031489.g002
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forms of information in identifying genetic contributions to complex
traits. Linkage analyses are used with family data to find broad
genomic regions that contain putative disease loci, while association
analysescanidentifymuchsmallerregions,eithera causalvariantor
one which is in linkage disequilibrium with such a disease-causing
locus. While association can generally detect smaller effects than
linkage, association is limited to detecting variants that are either
directly assayed or are in strong LD with typed SNP. These are
more likely to be common variants, which generally have small
effects. In contrast, linkage in families can detect rare variants
specific to a subset of families and these rare variants are likely to
have larger effects. An advantage of family data in association
analyses is to provide a perfect control for population stratification.
Ourcombined linkage and association designbrings the best ofboth
worlds to the problem at hand. If significant linkage is detected in
the presence of significant association, it suggests that the putative
locus is not the functional gene, but rather is a locus in
disequilibrium with a trait locus. In contrast, if the linkage signal
disappears at a point of significant association, this is suggestive that
the associated SNP is, in fact, causal. In addition, all our subjects are
Hong Kong Han Chinese, a relatively homogeneous group with
regard to genetic background and environmental risk factors.
Nevertheless,ourfindingsarelimitedbyrelativelysmallsample size.
Furthermore, as prior studies have reported ethnic differences in
frequencies of alleles and effects of genes involved in blood pressure
traits [52,53], the novel loci we found may not be generalized to
other population groups and await further replication.
Supporting Information
Figure S1 Whole genome association scan and QQ plots
for dichotomous hypertension.
(TIF)
Figure S2 Plots of whole genome association scan
results for three quantitative traits using within-family
tests. SNPs from each chromosome are represented by a different
color and ordered by physical location.
(TIF)
Figure S3 Plots of whole genome association scan
results for three quantitative traits using the total
association test. SNPs from each chromosome are represented
by a different color and ordered by physical location.
(TIF)
Figure S4 QQ plots of P-values observed vs expected
under the null hypothesis, for the three quantitative
traits (DBP, SBP and MAP), obtained from tests of
within-family and total association.
(TIF)
Figure S5 QQ plots for previous reported SNPs by eight
genome-wide scan studies as well as candidate gene
studies in our association analysis of within-family and
total tests for DBP, SBP and MAP.
(TIF)
Figure S6 Results of the genome-wide linkage analysis
are illustrated for DBP, SBP and MAP, respectively. The
multipoint LOD scores are shown on the y-axis plotted against the
chromosomal position on the x-axis.
(TIF)
Figure S7 Three regions (AGT, 2q14-q23 and DRD2)
with evidence of linkage are shown in the results of
linkage analysis as illustrated for DBP, SBP and MAP,
respectively. The multipoint LOD scores are shown on the y-
axis plotted against the chromosomal position on the x-axis.
(TIF)
Figure S8 QQ plots of the Merlin-Regress peak findings
in within-family association analysis for DBP.
(TIF)
Table S1 Strongest associations obtained for dichoto-
mous hypertensive/normotensive disease status, sorted
by P value.
(PDF)
Table S2 Strongest associations obtained from both
within and total tests for DBP, SBP and MAP, sorted by P
value.
(PDF)
Table S3 Relationship of SNPs at 9 significant loci to
three blood pressure traits.
(PDF)
Table S4 Family-based association results for all three
quantitative traits (DBP, SBP and MAP) for the 101 SNPs
previously reported.
(XLSX)
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